{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:28:27Z","timestamp":1767972507214,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.03.056","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T23:07:15Z","timestamp":1429139235000},"page":"3047-3055","source":"Crossref","is-referenced-by-count":16,"title":["Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014"],"prefix":"10.1016","volume":"33","member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.03.056_bib0355","series-title":"Global tuberculosis report 2014","author":"WHO","year":"2014"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0360","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0365","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0375","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","article-title":"Diagnosis of childhood tuberculosis and host RNA expression in Africa","volume":"370","author":"Anderson","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0380","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/joim.12212","article-title":"Recent advances towards tuberculosis control: vaccines and biomarkers","volume":"275","author":"Weiner","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0385","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ng.590","article-title":"Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved","volume":"42","author":"Comas","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0390","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0395","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ni1105-1063","article-title":"From bacteriology to immunology: the dualism of specificity","volume":"6","author":"Kaufmann","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0400","series-title":"La vaccination pr\u00e9ventive contre la tuberculose par le BCG","author":"Calmette","year":"1927"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0405","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0410","unstructured":"WHO. BCG vaccine."},{"key":"10.1016\/j.vaccine.2015.03.056_bib0415","doi-asserted-by":"crossref","first-page":"e26434","DOI":"10.1371\/journal.pone.0026434","article-title":"Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses","volume":"6","author":"Checkley","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0420","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clini Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60195-1","article-title":"Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates","author":"Jenkins","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0430","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette\u2013Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0435","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0440","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0445","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0450","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","article-title":"The primary mechanism of attenuation of bacillus Calmette\u2013Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0455","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/14760584.4.4.541","article-title":"Tuberculosis: from genome to vaccine","volume":"4","author":"de Jonge","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0460","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0465","doi-asserted-by":"crossref","first-page":"e1002507","DOI":"10.1371\/journal.ppat.1002507","article-title":"Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death","volume":"8","author":"Simeone","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0470","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.4049\/jimmunol.0801694","article-title":"Antigen load governs the differential priming of CD8T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection","volume":"182","author":"Ryan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0475","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12251","article-title":"Release of mycobacterial antigens","volume":"264","author":"Majlessi","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0480","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0485","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0490","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","article-title":"PEST sequences and regulation by proteolysis","volume":"21","author":"Rechsteiner","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0495","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.290.5493.992","article-title":"A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity","volume":"290","author":"Decatur","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0500","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir592","article-title":"Recombinant BCG \u0394ureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses","author":"Desel","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0505","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1016\/j.vaccine.2012.10.031","article-title":"The recombinant tuberculosis vaccine rBCG \u0394ureC:: hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells","volume":"30","author":"Farinacci","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0510","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/infdis\/jiu347","article-title":"Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette\u2013Gu\u00e9rin \u0394ureC:: hly vaccine's superior protection against tuberculosis","volume":"210","author":"Vogelzang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0515","article-title":"The recombinant BCG \u0394ureC:: hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation","author":"Saiga","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0520","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","article-title":"Mycobacterium bovis Bacille Calmette\u2013Gu\u00e9rin strains secreting listeriolysin of Listeria monocytogenes","volume":"95","author":"Hess","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0525","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/hv.6.8.13188","article-title":"Learning from natural infection for rational tuberculosis vaccine design: from basic science to translational research","volume":"6","author":"Kaufmann","year":"2010","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0530","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0535","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0540","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1016\/j.vaccine.2005.03.001","article-title":"New live mycobacterial vaccines: the Geneva Consensus on essential steps towards clinical development","volume":"23","author":"Kamath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0545","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva Consensus: recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0550","doi-asserted-by":"crossref","first-page":"e3496","DOI":"10.1371\/journal.pone.0003496","article-title":"PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence","volume":"3","author":"Gonzalo-Asensio","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0555","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/cmi.12169","article-title":"ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis","volume":"15","author":"Aguilo","year":"2013","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0560","doi-asserted-by":"crossref","first-page":"e1004183","DOI":"10.1371\/journal.ppat.1004183","article-title":"The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis","volume":"10","author":"Solans","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0565","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.201141903","article-title":"Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory","volume":"42","author":"Nambiar","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0570","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS ONE"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2015.03.056_bib0575","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/313880","article-title":"Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis","volume":"30","author":"Waddell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0580","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1097\/00002030-200311070-00010","article-title":"Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial","volume":"17","author":"Vuola","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0585","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette\u2013Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"von Reyn","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0590","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1016\/j.vaccine.2010.09.041","article-title":"Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania","volume":"28","author":"Lahey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0595","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2014.03.047","article-title":"Therapeutic vaccines for tuberculosis \u2013 a systematic review","volume":"32","author":"Groschel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0600","doi-asserted-by":"crossref","first-page":"e10030","DOI":"10.1371\/journal.pone.0010030","article-title":"Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs","volume":"5","author":"Gil","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0605","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.vaccine.2009.09.134","article-title":"Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI","volume":"28","author":"Vilaplana","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0610","doi-asserted-by":"crossref","first-page":"e89612","DOI":"10.1371\/journal.pone.0089612","article-title":"Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection","volume":"9","author":"Nell","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0615","doi-asserted-by":"crossref","first-page":"32475","DOI":"10.1074\/jbc.M111.271809","article-title":"Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity","volume":"286","author":"Ferraris","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0620","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1515\/hsz-2012-0106","article-title":"Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates","volume":"393","author":"Petrera","year":"2012","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0625","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0630","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/CVI.00015-11","article-title":"Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens","volume":"18","author":"Johansen","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","author":"Sander","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0640","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2013.12.055","article-title":"BCG Deltazmp1 vaccine induces enhanced antigen specific immune responses in cattle","volume":"32","author":"Khatri","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0645","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette\u2013Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0650","first-page":"278","article-title":"The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0655","first-page":"732","article-title":"The spectrum of disease in children treated for tuberculosis in a highly endemic area","volume":"10","author":"Marais","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0660","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0665","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0670","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"Hanekom","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0675","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0680","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth weight infants in Guinea-Bissau: a randomized-controlled trial","author":"Jensen","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0685","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab \u2013 a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0690","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jis941","article-title":"Longitudinal changes in CD4+ T cell memory responses Induced by Bacille Calmette Guerin vaccination of newborns","author":"Soares","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0695","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/CVI.00427-13","article-title":"Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG","volume":"20","author":"Fletcher","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.03.056_bib0700","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette\u2013Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15003667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T04:45:00Z","timestamp":1651725900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15003667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":70,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0264410X15003667"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}